Skip to main content

Table 2 Complications and mortality

From: Long-term clinical outcome of patients with severe atherosclerotic renal artery stenosis after percutaneous transluminal renal angioplasty

Observation period, median(IQR) 83(49,106) months
Renal death, n(%) 4(5)
Heart failure, n(%) 17(24)
CCE, n(%) 4(5.4)
Re-PTRA, n(%) 10(14)
Mortality, n(%) 14(19)
Cardiac 6/14(43)
Cancer 5/14(36)
Infection 2/14(14)
Mesenteric infarction 1/14(7)
  1. CCE cholesterol crystal embolism
  2. PTRA percutaneous transluminal renal angioplasty